A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).

NCT00974974 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

471

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: IPX066
DRUG: IR CD-LD

Sponsor

Impax Laboratories, LLC